Inactive Instrument

News PHARMING GROUP Euronext Amsterdam

Equities

NL0000377018

End-of-day quote Euronext Amsterdam Other stock markets
- ^EUR	-

May. 31	Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug	MT
May. 21	Transcript : Pharming Group N.V. - Shareholder/Analyst Call

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug	May. 31	MT
Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K	May. 30	PU
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union	May. 30	GL
Pharming N : Physical Settlement Notice 2029 Convertible Bonds	May. 28	PU
Pharming N : Publication of Voting Results of the AGM 2024	May. 23	PU
Pharming N : Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	May. 22	PU
Pharming N : Presentation AGM 2024	May. 21	PU
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	May. 21	GL
Transcript : Pharming Group N.V. - Shareholder/Analyst Call	May. 21
Pharming Group to participate in May investor conference	May. 20	GL
Pharming N : Presentatie - mei 2024	May. 16	PU
Pharming N : Corporate Presentation - May 2024	May. 15	PU
Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript	May. 15	PU
Pharming N : Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025	May. 15	PU
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025	May. 15	GL
Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024	May. 08
Pharming N : 1Q 2024 Financial Results Presentation - May 8, 2024	May. 08	PU
Pharming Group reports first quarter 2024 financial results and provides business update	May. 08	AQ
Pharming Group reports first quarter 2024 financial results and provides business update	May. 08	GL
Pharming Group N.V. Provides Revenue Guidance for 2024	May. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PHARMING GROUP Euronext Amsterdam

Equities

NL0000377018

Summary

Filters